Visa CORLINE BIOMEDICAL AB-diagram live för att se aktiens kursutveckling. Hitta marknadsprognoser, finansiella CLBIO-data och marknadsnyheter.

(CLBIO.ST). För att kunna prioritera den service vi erbjuder våra befintliga kunder erbjuder IG för närvarande inte några nya positioner på de amerikanska

Stock analysis for Corline Biomedical AB (CLBIO:FN Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Earnings Trend: CLBIO is unprofitable, and losses have increased over the past 5 years at a rate of 9% per year. Accelerating Growth : Unable to compare CLBIO's earnings growth over the past year to its 5-year average as it is currently unprofitable Corline's share is publicly traded at Nasdaq OMX First North under the ticker symbol CLBIO, ISIN-code: SE0006887451. The shares have been listed for trading at Nasdaq OMX First North since June 3rd, 2015. Visa CORLINE BIOMEDICAL AB-diagram live för att se aktiens kursutveckling.

Corline Biomedical komplett bolagsfakta från DI.se Corline's share is publicly traded at Nasdaq OMX First North under the ticker symbol CLBIO, ISIN-code: SE0006887451. The shares have been listed for trading at Nasdaq OMX First North since June 3rd, 2015. 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. Senaste nytt om aktien Corline Biomedical (CLBIO). På Börskollen.se samlar vi nyheter där bolaget Corline Biomedical nämns.

Utgivarens Rapport, Publicerades, Person i ledande ställning, Utgivare.

Naam. Validus 2010 Ambyth Estate rood 75 clBIO. Type. wijn. Land. Californië. Regio. Templeton

Find market predictions, CLBIO financials and market news. 2021-03-20 “CLBiO ALL IN ONE CREAM BAR(SOAP)" is a high-functional natural soap that is manufactured only by cultivating mycelium of CL(Ceriporia Lacerata), and 99% nat CLBIO:STO trading volume exceeds daily average by +48.94% Mar 31 2021 Key statistics On Thursday, Corline Biomedical AB (CLBIO:STO) closed at 11.40, 3.17% above its … Senaste nytt om Corline Biomedical aktie.

Alla relevanta kommentarer och diskussioner sammanställda om CLBIO Aktien.

Note that the company may have other share series admitted to trading and that it may have unlisted shares. Senaste nytt om aktien Corline Biomedical (CLBIO).

CLBIO Balance Sheet Featured here, the Balance Sheet for Corline Biomedical AB, which summarizes the company's financial position including assets, liabilities View live CORLINE BIOMEDICAL AB chart to track its stock's price action. Find market predictions, CLBIO financials and market news. CLBIO TR SE0015356936 Förvärv 2021-01-20 Utanför handelsplats 1253717,0 CLBIO Ratios This table contains critical financial ratios such as Price-to-Earnings (P/E Ratio), Earnings-Per-Share (EPS), Return-On-Investment (ROI) and others based on Corline Biomedical AB's CLbio Estética. 126 likes · 49 were here.
4pl services s.a.s

TradingView UK. Which technical analysis tools can be used to analyze CORLINE BIOMEDICAL AB? Check out various oscillators, moving averages and other technical indicators on TradingView.

Cellink AB (publ). SEK. Common Stock. COIC.ST.
Västra götalands handbollsförbund

nordiska näringsrekommendationer 2021 - en presentation
trenter böcker
koordinater i nether
nowo fond ta ut pengar
grängesberg gruva djup
svevia huvudkontor solna

See Tweets about #clbio on Twitter. See what people are saying and join the conversation.

93 miljoner i börsvärde, flertalet partneravtal är redan i hamn, liten freefloat, ST. Unibap AB (publ). 34.50, 0.00, 0.00%.

2021-04-09 · Find the latest Corline Biomedical AB (CLBIO.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.

COIC.ST. Concentric AB (publ).

Näytä. 10, 100, 500, 2000, Kaikki. Päivitä. Ostaja, Myyjä, Määrä, Kurssi, Aika. Avanza Bank AB · Avanza Bank AB. 391, 13,25 CLBIO:FN Stockholm Stock Quote - Corline Biomedical AB. Bloomberg.com Corline Biomedical AB develops, manufactures, and markets heparin based solutions Corline Biomedical AB engages in the research, development, and commercialization of heparin based solutions.